African swine fever (ASF) is among the most devastating threats to global pig production. The virus has spread to more than 70 countries and has wiped out over 40 percent of pig herds in some parts of Asia, with no licensed vaccine or antiviral treatment available. Because early-stage ASF presents nonspecific clinical signs that are indistinguishable from other porcine febrile diseases, containment depends entirely on rapid diagnosis and prompt depopulation of infected herds. This diagnostic gap—between slow centralized laboratory testing and unreliable field assays—has become the critical bottleneck in protecting animal health.

Traditional laboratory-based PCR remains the gold standard for sensitivity, but its reliance on centralized facilities, trained personnel, and multi-step sample preparation makes it ill-suited for outbreak response at the farm level. Conventional rapid field tests offer speed but often suffer from poor sensitivity, leaving veterinarians and producers caught between waiting days for laboratory confirmation or acting on unreliable results. This trade-off between speed and accuracy is precisely what modern diagnostic development aims to resolve.

Recent innovations are closing this gap. Isothermal amplification methods now deliver near-laboratory sensitivity within roughly half an hour using field samples, with agreement rates against PCR approaching 95–100 percent. Extraction-free molecular platforms have shortened detection to about 20 minutes while maintaining high sensitivity and specificity. Equipment-free visual strips enable on-site surveillance without specialized instrumentation, and assays adapted for feed testing address an often-overlooked transmission route. These diverse approaches share a common goal: bringing laboratory-grade accuracy to the point of need, whether on a farm, at a border checkpoint, or in a regional veterinary station.

In summary, ASF control hinges on speed. Without vaccines, the only defense is detecting infection before it spreads beyond containment. The shift from centralized laboratory testing toward field-deployable, rapid diagnostic platforms represents a fundamental change in outbreak strategy—one that empowers frontline veterinarians and producers to act within minutes rather than days. Investing in rapid detection is not merely a technical improvement; it is an essential component of global animal health security.